To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - Appointment of Alternate Director

Release Date: 08/04/2016 08:00
Code(s): MEI     PDF:  
Wrap Text
Appointment of Alternate Director

Mediclinic International plc (the “Company”)
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88

Appointment of Alternate Director

The Board of Mediclinic International plc is pleased to announce that as of 7 April 2016, Mr Jannie
Durand, a non-executive director of the Company, has appointed Mr Pieter Uys as his alternate
director.

Since 2013, Mr Uys has held the position of Head of Strategic Investment at Remgro Limited, a
Johannesburg Stock Exchange listed investment company with meaningful interests in a number of
businesses across the world. Prior to joining Remgro, Mr Uys was a founding member and ultimately
became the CEO of Vodacom Group, one of the leading mobile networks in Africa. Mr Uys holds a
MEng (Electrical) and an MBA from the University of Stellenbosch, South Africa.

There is no further information to be disclosed in accordance with Listing Rule 9.6.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information, please contact:

Company Secretary
Victoria Dalby
Capita Company Secretarial Services Limited
+44 (0)207 954 9528

8 April 2016

Date: 08/04/2016 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story